Gilead Will Donate Truvada to U.S. for H.I.V. Prevention

The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives.
The New York Times
By DONALD G. McNEIL Jr. from NYT Health https://nyti.ms/2VRY6qm
May 8, 2019 at 02:00PM